GRAIL Inc

Financials

영업활동으로 인한 현금 -577.16 M-299.01 M -299.01 M 투자 활동으로 인한 현금 -551.01 M-85.05 M -85.05 M 재무활동으로 인한 현금 1.24 B423.32 M 423.32 M 잉여 현금 흐름 -582.36 M-299.92 M -299.92 M

GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021. In June 2021 GRAIL launched their liquid biopsy, or multi-cancer early detection test, which they called Galleri test. In 2023 EU regulators ordered Grail to be spun-out from Illumina which was completed on June 24, 2024.